Medtronic Debt to Equity Ratio 2010-2025 | MDT

Current and historical debt to equity ratio values for Medtronic (MDT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Medtronic debt/equity for the three months ending April 30, 2025 was 0.53.
Medtronic Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-04-30 $43.42B $48.26B 0.90
2025-01-31 $40.36B $49.62B 0.81
2024-10-31 $41.33B $48.72B 0.85
2024-07-31 $41.59B $48.16B 0.86
2024-04-30 $39.56B $50.42B 0.79
2024-01-31 $38.84B $52.00B 0.75
2023-10-31 $38.44B $51.65B 0.74
2023-07-31 $39.41B $51.37B 0.77
2023-04-30 $39.28B $51.67B 0.76
2023-01-31 $42.52B $51.62B 0.82
2022-10-31 $41.18B $52.06B 0.79
2022-07-31 $37.07B $52.84B 0.70
2022-04-30 $38.26B $52.72B 0.73
2022-01-31 $39.09B $52.71B 0.74
2021-10-31 $39.60B $52.16B 0.76
2021-07-31 $40.14B $51.66B 0.78
2021-04-30 $41.48B $51.60B 0.80
2021-01-31 $46.34B $50.93B 0.91
2020-10-31 $45.57B $50.32B 0.91
2020-07-31 $43.46B $50.44B 0.86
2020-04-30 $39.82B $50.87B 0.78
2020-01-31 $40.87B $51.95B 0.79
2019-10-31 $40.33B $50.72B 0.80
2019-07-31 $40.77B $50.50B 0.81
2019-04-30 $39.48B $50.21B 0.79
2019-01-31 $38.79B $49.94B 0.78
2018-10-31 $38.44B $49.71B 0.77
2018-07-31 $39.39B $50.33B 0.78
2018-04-30 $40.57B $50.82B 0.80
2018-01-31 $45.46B $50.34B 0.90
2017-10-31 $42.88B $51.58B 0.83
2017-07-31 $49.46B $50.79B 0.97
2017-04-30 $49.53B $50.33B 0.98
2017-01-31 $48.09B $49.49B 0.97
2016-10-31 $48.11B $50.29B 0.96
2016-07-31 $47.71B $50.89B 0.94
2016-04-30 $47.58B $52.06B 0.91
2016-01-31 $51.89B $50.82B 1.02
2015-10-31 $52.68B $52.27B 1.01
2015-07-31 $51.82B $52.81B 0.98
2015-04-30 $53.46B $53.23B 1.00
2015-01-31 $35.06B $20.17B 1.74
2014-10-31 $19.34B $19.44B 1.00
2014-07-31 $18.31B $19.25B 0.95
2014-04-30 $18.50B $19.44B 0.95
2014-01-31 $17.88B $19.35B 0.92
2013-10-31 $17.72B $18.74B 0.95
2013-07-31 $16.45B $18.52B 0.89
2013-04-30 $16.23B $18.67B 0.87
2013-01-31 $17.11B $17.84B 0.96
2012-10-31 $16.79B $17.18B 0.98
2012-07-31 $16.00B $17.26B 0.93
2012-04-30 $15.71B $17.11B 0.92
2012-01-31 $14.74B $17.17B 0.86
2011-10-31 $15.01B $16.74B 0.90
2011-07-31 $14.75B $16.34B 0.90
2011-04-30 $14.71B $15.97B 0.92
2011-01-31 $15.24B $15.36B 0.99
2010-10-31 $14.49B $14.83B 0.98
2010-07-31 $14.06B $14.60B 0.96
2010-04-30 $13.46B $14.63B 0.92
2010-01-31 $10.85B $14.32B 0.76
2009-10-31 $10.68B $13.61B 0.79
2009-07-31 $10.43B $13.14B 0.79
2009-04-30 $10.41B $13.18B 0.79
2009-01-31 $9.70B $13.06B 0.74
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $112.813B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.364B 28.06
Stryker (SYK) United States $146.969B 30.73
Boston Scientific (BSX) United States $146.968B 36.79
EssilorLuxottica (ESLOY) France $131.277B 0.00
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $49.016B 27.92
ResMed (RMD) United States $37.047B 27.83
Agilent Technologies (A) United States $34.235B 22.32
GE HealthCare Technologies (GEHC) United States $33.847B 16.07
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.399B 16.10
Insulet (PODD) United States $21.023B 82.52
Zimmer Biomet Holdings (ZBH) United States $18.780B 12.06
Baxter (BAX) United States $16.278B 12.15
Smith & Nephew SNATS (SNN) United Kingdom $13.165B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.273B 21.83
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $4.281B 19.13
Perrigo (PRGO) Ireland $3.794B 9.62
Haemonetics (HAE) United States $3.466B 15.79
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.367B 24.83
Envista Holdings (NVST) United States $3.244B 26.96
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.091B 14.38
LeMaitre Vascular (LMAT) United States $1.890B 42.24
AtriCure (ATRC) United States $1.653B 0.00
Acuren (TIC) United States $1.314B 0.00
Neogen (NEOG) United States $1.268B 16.22
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.136B 0.00
Green Thumb Industries (GTBIF) United States $1.063B 23.91
Kestra Medical Technologies (KMTS) United States $1.053B 0.00
Phibro Animal Health (PAHC) United States $0.987B 12.61
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.640B 0.00
Evolus (EOLS) United States $0.636B 0.00
Capricor Therapeutics (CAPR) United States $0.634B 0.00
Owens & Minor (OMI) United States $0.629B 5.22
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Tilray Brands (TLRY) Canada $0.422B 0.00
Surmodics (SRDX) United States $0.418B 0.00
VAREX IMAGING (VREX) United States $0.367B 13.50
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.334B 59.50
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Canopy Growth (CGC) Canada $0.276B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.00
ZimVie (ZIMV) United States $0.266B 12.09
Sanara MedTech (SMTI) United States $0.265B 0.00
Sanuwave Health (SNWV) United States $0.264B 0.00
Quanterix (QTRX) United States $0.256B 0.00
Cresco Labs (CRLBF) United States $0.253B 0.00
Omeros (OMER) United States $0.227B 0.00
Biote (BTMD) United States $0.227B 6.37
OraSure Technologies (OSUR) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.216B 57.30
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.16
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.105B 0.00
Veru (VERU) United States $0.098B 0.00
Fonar (FONR) United States $0.092B 11.88
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.074B 0.00
Apyx Medical (APYX) United States $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Nephros (NEPH) United States $0.041B 55.43
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00